VSTM Archived Articles

Verastem Oncology (NASDAQ:VSTM): A Resilient Biopharmaceutical Tackling RAS/MAPK-Driven Cancers


Verastem, Inc. (NASDAQ:VSTM): A Precision Oncology Pioneer Unlocking New Frontiers in KRAS-Driven Cancers


Verastem (NASDAQ:VSTM) Poised for Breakthrough in Oncology Pipeline